Hantavirus: Complete Guide to Symptoms, Transmission, and 2026 Outbreak

Hantavirus is a genus of single-stranded, negative-sense RNA viruses in the family Hantaviridae, order Bunyavirales. Unlike most arboviruses, hantaviruses are not transmitted by arthropods; they are maintained in rodent reservoirs and shed in saliva, urine, and feces. Humans are infected primarily by inhaling aerosolized rodent excreta, which makes the virus a quintessential spillover pathogen.

First isolated near the Hantan River in Korea in 1976, the genus now contains more than 40 recognized species. Two clinical syndromes dominate human disease: Hemorrhagic Fever with Renal Syndrome (HFRS) in Eurasia, and Hantavirus Pulmonary Syndrome (HPS), also called Hantavirus Cardiopulmonary Syndrome (HCPS), in the Americas. The 2026 outbreak signal that PredictHanta tracks is driven primarily by the New World viruses, especially Andes virus (ANDV) and Sin Nombre virus (SNV).

How hantaviruses spread

Each hantavirus species has co-evolved with a single rodent host. The relationship is so tight that the geographic range of the virus is effectively the geographic range of its reservoir.

• Inhalation of aerosolized excreta — the dominant route. Sweeping a barn, opening a long-closed cabin, or working in dusty crawl spaces creates aerosols that carry virions deep into the lungs.
• Bite — rare, but documented for several New World species when handling live rodents.
• Direct contact with broken skin or mucous membranes, via contaminated dust or rodent saliva.
• Person-to-person transmission — confirmed only for Andes virus, in clusters in Argentina and Chile. This is why ANDV is the species global health authorities watch most closely. Andes virus deep dive →

Symptoms of hantavirus infection

After an incubation of 1–8 weeks, the disease unfolds in two phases. The prodromal phase mimics influenza: fever, myalgia (especially thighs, hips, back), headache, fatigue, and gastrointestinal symptoms. Cough is initially mild or absent. This phase typically lasts 3–7 days.

The cardiopulmonary phase begins abruptly with shortness of breath, hypotension, and pulmonary edema. In HPS specifically, capillary leakage floods the alveoli, oxygenation collapses, and patients deteriorate over hours rather than days. ECMO support has materially improved outcomes since 2010, but remains unavailable in most rural settings.

For HFRS (Old World species: Hantaan, Seoul, Puumala, Dobrava), the dominant signs are thrombocytopenia, acute kidney injury, and capillary fragility leading to hemorrhage. Mortality varies from below 1% (Puumala) to over 12% (Hantaan).

Hantavirus mortality and case-fatality rate

These figures are aggregated from CDC, ECDC and WHO surveillance reports 2010–2025 and are weighted to reflect contemporary care. CFRs in resource-constrained settings can run materially higher.

Diagnosis

Diagnosis combines clinical suspicion with serology and molecular assays:

• IgM ELISA against viral nucleocapsid — positive within ~7 days of symptom onset.
• RT-PCR on whole blood or serum — confirmatory in early disease.
• Plaque-reduction neutralization test (PRNT) — for species-level differentiation, generally a research-tier assay.
• Chest imaging — bilateral interstitial edema is a hallmark of HPS, often misread as ARDS or atypical pneumonia.

Treatment

There is no FDA-approved antiviral for any hantavirus. Care is supportive and time-critical: aggressive fluid management, early mechanical ventilation, vasopressors, and ECMO at tertiary centers. Ribavirin showed efficacy against HFRS when administered within 4 days of symptom onset; HPS data is more equivocal.

Several monoclonal-antibody candidates targeting the Gn glycoprotein of ANDV and SNV are in early-phase trials. A bivalent HFRS vaccine (Hantavax) is licensed in South Korea and China; it does not protect against New World viruses.

Why 2026 matters

Three signals converged in early 2026:

1. An ANDV cluster in Patagonia exhibiting probable household-level human-to-human transmission.
2. The MV Hondius cruise-ship outbreak that exported cases across multiple jurisdictions.
3. Detection of ANDV-positive sera in a European traveler who had not visited South America — the first putative autochthonous European case.

These developments are why the WHO Emergency Committee began deliberating a possible PHEIC declaration and why prediction-market interest spiked. Track the live signal on the outbreak map or trade against the consensus across our market book.

Prevention

• Seal entry points ≤6 mm to exclude rodents from dwellings.
• Wet-clean rodent-soiled surfaces with 1:10 bleach; never sweep or vacuum dust.
• Air out closed cabins for ≥30 minutes before entering.
• Wear N95 + nitrile gloves for any rodent excreta cleanup.
• For occupational exposure (rangers, grain workers, vets), enroll in surveillance and consider HFRS vaccination if travelling to endemic Asia.